1 paper
A measure of prediction performance rose from 0.79 for symptoms alone to 0.90 when blood biomarkers were added.A measure of prediction performance rose from 0.79 for symptoms alone to 0.90 when blood biomarkers were added.
In a 52-week randomised trial, disease rating scores rose by 2.45 points with the supplement compared with a 0.27-point fall with placebo.In a 52-week randomised trial, disease rating scores rose by 2.45 points with the supplement compared with a 0.27-point fall with placebo.
A 22-question measure covering seven symptom areas was supported by three online studies of 2,915 US women aged 21–85.A 22-question measure covering seven symptom areas was supported by three online studies of 2,915 US women aged 21–85.
In over 119,000 adults, 89.2% of COPD cases were underdiagnosed, which was associated with a 1.53 hazard ratio for mortality compared to having no COPD.In over 119,000 adults, 89.2% of COPD cases were underdiagnosed, which was associated with a 1.53 hazard ratio for mortality compared to having no COPD.